1-234607219-T-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_182972.3(IRF2BP2):c.1682A>T(p.Asn561Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000681 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N561S) has been classified as Uncertain significance.
Frequency
Consequence
NM_182972.3 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency, common variable, 14Inheritance: AD, Unknown Classification: LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF2BP2 | ENST00000366609.4 | c.1682A>T | p.Asn561Ile | missense_variant | Exon 2 of 2 | 1 | NM_182972.3 | ENSP00000355568.3 | ||
IRF2BP2 | ENST00000366610.8 | c.1634A>T | p.Asn545Ile | missense_variant | Exon 2 of 2 | 1 | ENSP00000355569.3 | |||
ENSG00000228830 | ENST00000436039.1 | n.212T>A | non_coding_transcript_exon_variant | Exon 1 of 2 | 3 | |||||
IRF2BP2 | ENST00000491430.1 | n.*12A>T | downstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251214 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461878Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727246 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74366 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1682A>T (p.N561I) alteration is located in exon 2 (coding exon 2) of the IRF2BP2 gene. This alteration results from a A to T substitution at nucleotide position 1682, causing the asparagine (N) at amino acid position 561 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 561 of the IRF2BP2 protein (p.Asn561Ile). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with IRF2BP2-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at